A phase II clinical trial is underway at the Department of Gastroenterology at Royal Perth Hospital in Australia among several medical institutes and the Cell and Tissue Therapies WA.
Out of 15 patients that completed the trial, 12 of them responded to the treatment. Eight of them went into disease remission.
More Articles on Gastroenterology:
Olympus Launches Medical Technology Website
Drs. Renjy Vattasseril, Anthony Masciarelli Join Cape Regional Physicians Associates
NIH Grants Medical College of Wisconsin $2M to Study GERD
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
